Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MLNR | O43193 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10626116 | 0.94 | FDPS (0.39) | TSHRMAPK1MEN1KMT2AFDPS | |
| SCHEMBL12371288 | 0.90 | CYP2D6 (0.36) | TSHRMEN1KMT2ACHRNB4CHRNA3 | |
| SCHEMBL593510 | 0.79 | CHRNA3 (0.37) | CHRNB4CHRNA3FDPSHRH3 | |
| SCHEMBL593996 | 0.79 | CHRNA3 (0.37) | CHRNB4CHRNA3FDPSHRH3 | |
| SCHEMBL197631 | 0.79 | — | — | |
| SCHEMBL2908604 | 0.79 | FDPS (0.38) | TSHRMEN1KMT2ACHRNB4CHRNA3 | |
| SCHEMBL5696915 | 0.79 | — | — | |
| SCHEMBL1190914 | 0.79 | — | — | |
| SCHEMBL12471863 | 0.78 | HRH3 (0.36) | TSHRMEN1KMT2ACHRNB4CHRNA3 | |
| SCHEMBL592511 | 0.78 | TSHR (0.36) | TSHRCHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988483-B2 | Pyrrolidine-based catalysts for use in polyurethane materials | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-06-05 | — | — | US | claimed |
| EP-3161029-A1 | PYRROLIDINE-BASED CATALYSTS FOR USE IN POLYURETHANE MATERIALS | Huntsman Petrochemical LLC (US) | 2017-05-03 | — | — | EP | claimed |
| US-20170101501-A1 | PYRROLIDINE-BASED CATALYSTS FOR USE IN POLYURETHANE MATERIALS | HUNTSMAN PETROCHEMICAL LLC | 2017-04-13 | — | — | US | claimed |
| WO-2015200408-A1 | PYRROLIDINE-BASED CATALYSTS FOR USE IN POLYURETHANE MATERIALS | HUNTSMAN PETROCHEMICAL LLC (US) | 2015-12-30 | — | — | WO | claimed |
| US-9988483-B2 | Pyrrolidine-based catalysts for use in polyurethane materials | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-06-05 | — | — | US | disclosed |
| US-20170101501-A1 | PYRROLIDINE-BASED CATALYSTS FOR USE IN POLYURETHANE MATERIALS | HUNTSMAN PETROCHEMICAL LLC | 2017-04-13 | — | — | US | disclosed |
| EP-1575943-A1 | 3-CYANO-QUINOLINE DERIVATIVES | AstraZeneca AB (SE) | 2005-09-21 | — | — | EP | disclosed |
| EP-1528925-A1 | QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | Astrazeneca AB (SE) | 2005-05-11 | — | — | EP | disclosed |
| EP-1521751-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS MEK INHIBITORS | Astrazeneca AB (SE) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004041811-A1 | 3-CYANO-QUINOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2004-05-21 | — | — | WO | disclosed |
| WO-2004004732-A1 | QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004005284-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS MEK INHIBITORS | ASTRAZENECA AB (SE) | 2004-01-15 | — | — | WO | disclosed |
| US-4767767-A | ANALGESIC, ANTIINFLAMMATORY AGENT | FERRER INTERNACIONAL S.A. (ES) | 1988-08-30 | — | — | US | disclosed |
| EP-0094065-A2 | 2-Aminobenzoic acid derivatives, a process for their preparation and pharmaceutical compositions | FERRER INTERNACIONAL, S.A. (ES) | 1983-11-16 | — | — | EP | disclosed |